Karen Colonias to step down as CEO on December 31, 2022, and retire from the Company on June 30, 2023
Michael Olosky to succeed Karen Colonias as Chief Executive Officer on January
Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) has set up a clinical research program for the treatment of strokes, focused on its proprietary DMT analogue, AP-188. The company is also planning to begin a Phase 1 clinical trial in 2022’s fourth quarter.
The Cathie Wood-led and closely followed Ark Invest fund is doubling down on the overarching idea that emerging innovation platforms will radically transform the global economy by creating a new chief futurist role.
Travel services provider Yatra Online Inc (NASDAQ:YTRA) has appointed Rohan Mittal as Group Chief Financial Officer (CFO) effective September 8. Mittal brings…
Shopify Inc (NYSE: SHOP) announced critical leadership changes. It appointed Jeff Hoffmeister as the CFO. Hoffmeister succeeds Amy Shapero, who stepped down…
Shopify Announces Leadership Changes
Kaz Nejatian Promoted to Chief Operating Officer Succeeding Toby Shannan, Who Will Transition to Special Advisor and Board Member
Jeff Hoffmeister Appointed Chief Financial Officer
PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.
Target Corp (NYSE: TGT) shares are trading higher Wednesday alongside several retailers amid overall market strength as stocks rebound from recent weakness. Target also announced leadership changes Wednesday morning.
Freshpet Inc (NASDAQ:FRPT) said its Chief Financial Officer Heather Pomerantz has decided to step down to pursue other opportunities effective September…